Get Congenital Syphilis Treatment Online

Congenital syphilis is a bacterial infection caused by Treponema pallidum that is transmitted from a mother to her baby during pregnancy through the placenta or during delivery. It can occur at any stage of maternal syphilis infection, though the risk is highest with early-stage maternal infection.

Symptoms in newborns can include skin rash (often involving the palms and soles), hepatosplenomegaly (enlarged liver and spleen), jaundice, bone pain or swelling, nasal discharge sometimes called snuffles, low birth weight, and anemia. Some infants show no symptoms at birth but develop problems weeks or months later.

Diagnosis involves maternal serologic testing (RPR and confirmatory treponemal tests) during prenatal care and at delivery, along with infant evaluation including nontreponemal titers (RPR or VDRL), physical examination, complete blood count, liver function tests, long bone X-rays, cerebrospinal fluid analysis, and ophthalmologic examination in suspected cases.

The standard treatment is aqueous crystalline penicillin G or procaine penicillin G given intravenously or intramuscularly for 10 days, depending on the clinical category and severity. Benzathine penicillin G is used in limited situations for infants in lower-risk categories. Treatment is determined by a physician based on clinical findings and serologic results.

Yes. Congenital syphilis is largely preventable through routine prenatal syphilis screening and timely treatment of infected mothers. The CDC recommends screening at the first prenatal visit, at 28 weeks of gestation, and again at delivery in high-prevalence areas or in mothers with risk factors.

Untreated or late-diagnosed congenital syphilis can lead to serious complications including interstitial keratitis (eye inflammation leading to vision loss), hearing loss, tooth abnormalities (Hutchinson teeth), bone and joint damage, neurological impairment, and saddle nose deformity. Early treatment significantly reduces the risk of these outcomes.

Doctronic uses an AI-guided evaluation to gather information about symptoms, test results, and relevant medical history. That information is reviewed by a licensed physician who can provide clinical guidance, discuss next steps, and where appropriate, coordinate prescriptions or referrals as part of a personalized treatment plan.

Yes. Doctronic works exclusively with licensed physicians, and all care decisions are doctor-reviewed and audited for quality. The platform is HIPAA-compliant, protecting your personal health information. Doctronic serves adults 18 and older in any U.S. state.